OTTAWA, Aug. 14, 2018 /CNW/ - Officials from Health Canada will hold a technical briefing to discuss the proposed special review decisions for thiamethoxam and clothianadin.
Officials will be available to answer questions from the media following a statement.
August 15, 2018
1:00 PM (EDT)
Media Technical Briefing will be held by teleconference only at:
Toll-free (Canada/US) dial-in number:
SOURCE Health Canada
For further information: Media Inquiries: Media Relations, Health Canada, (613) 957-2983, email@example.com